Cargando…
Synthesis of ST7612AA1, a Novel Oral HDAC Inhibitor, via Radical Thioacetic Acid Addition
ABSTRACT: BACKGROUND: In the expanding field of anticancer drugs, HDAC inhibitors are playing an increasingly important role. To date, four/five HDAC inhibitors have been approved by FDA. All these compounds fit the widely accepted HDAC inhibitors pharmacophore model characterized by a cap group, a...
Autores principales: | Battistuzzi, Gianfranco, Giannini, Giuseppe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5101637/ https://www.ncbi.nlm.nih.gov/pubmed/27917100 http://dx.doi.org/10.2174/1573407212666160504160556 |
Ejemplares similares
-
Preclinical antitumor activity of ST7612AA1: a new oral thiol-based histone deacetylase (HDAC) inhibitor
por: Vesci, Loredana, et al.
Publicado: (2014) -
Radical-Mediated Reactions of α-Bromo Aluminium Thioacetals, α-Bromothioesters, and Xanthates for Thiolactone Synthesis
por: McCourt, Ruairí O., et al.
Publicado: (2018) -
Synthesis and Degradation of Vinyl Polymers with Evenly Distributed Thioacetal Bonds in Main Chains: Cationic DT Copolymerization of Vinyl Ethers and Cyclic Thioacetals
por: Uchiyama, Mineto, et al.
Publicado: (2022) -
Antibody drug conjugates (ADCs) charged with HDAC inhibitor for targeted epigenetic modulation
por: Cini, Elena, et al.
Publicado: (2018) -
Regioselective Dehydration of Sugar Thioacetals under
Mild Conditions
por: Szpara, Rachel, et al.
Publicado: (2021)